CTLA-4 gene polymorphism regulates CTLA-4 mRNA stability and protein level in patients with ulcerative colitis

Chinese Journal of Medical Genetics

Volumn 27, Issue 6, 2010, Pages 603-609

  Chen, Zhi Tao ^a   Xia, Bing ^a   Jiang, Ting ^a   Zhou, Feng ^a   Zou, Kai Fang ^b   Ge, Liu Qing ^a  

^a WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

(AT)n repeats; Cytotoxic T lymphocyte associated antigen 4; Expression; Genetic polymorphism; Ulcerative colitis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MESSENGER RNA;

3' UNTRANSLATED REGION; ARTICLE; CHINA; COLON BIOPSY; CONTROLLED STUDY; DISEASE ACTIVITY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC RISK; GENOTYPE; HALF LIFE TIME; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA STABILITY; ULCERATIVE COLITIS;

ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, GENETIC; RNA STABILITY; RNA, MESSENGER; SOLUBILITY;

EID: 78650963273     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-9406.2010.06.001     Document Type: Article

References (15)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature, 2007, 448: 427-434. (Pubitemid 47123518)
2. Scalapino KJ, Daikh DI. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev, 2008, 223: 143-155.
3. Chen PL, Fann CS, Chang CC, et al. Family-based association study of cytotoxic T-lymphocyte antigen-4 with susceptibility to Graves' disease in Han population of Taiwan. Genes Immun, 2008, 9: 87-92.
4. Malquori L, Carsetti L, Ruberti G. The 3′ UTR of the human CTLA4 mRNA can regulate mRNA stability and translational efficiency. Biochim Biophys Acta, 2008, 1779: 60-65.
5. Jiang Y, Xia B. Association between the cytotoxic T lymphocyte antigen-4 gene microsatellite polymorphism and inflammatory bowel diseases in the Chinese. Chin J Intern Med, 2004, 43: 191-194.
6. Chinese IBD Working Group of Society of Gastroenterology of the Chinese Medical Association. Guideline of the diagnosis and treatment for the inflammatory bowel disease. Mod Dig Interv, 2008, 13: 139-145.
7. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 2008, 3: 1101-1108.
8. Loup F, Picard F, André VM, et al. Altered expression of alpha3-containing GABAA receptors in the neocortex of patients with focal epilepsy. Brain, 2006, 129: 3277-3289.
9. Huang D, Giscombe R, Zhou Y, et al. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener ' s granulomatosis. J Rheumatol, 2000, 27: 397-401.
10. Akamizu T, Sale MM, Rich SS, et al. Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid, 2000, 10: 851-858.
11. Wang XB, Kakoulidou M, Giscombe R, et al. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J Neuroimmunol, 2002, 130: 224-232. (Pubitemid 35240010)
12. Mansfield ES, Vainer M, Enad S, et al. Sensitivity, reproducibility, and accuracy in short tandem repeat genotyping using capillary array electrophoresis. Genome Res, 1996, 6: 893-903.
13. Gu M, Kakoulidou M, Giscombe R, et al. Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis. Clin Immunol, 2008, 128: 374-381.
14. Takara M, Kouki T, DeGroot LJ. CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease. Thyroid, 2003, 13: 1083-1089.
15. Read S, Malmstròm V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 (+) CD4 (+) regulatory cells that control intestinal inflammation. J Exp Med, 2000, 192: 295-302.